tiprankstipranks
Advertisement
Advertisement

Vimian AGM Backs Capital Flexibility and New Long-Term Incentive Plan

Story Highlights
  • Vimian’s AGM approved 2025 accounts, retained earnings, and re-elected the existing board and auditor while setting new remuneration levels.
  • Shareholders authorised major share issue and buyback capacity and adopted new share classes and a long-term incentive plan to support growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vimian AGM Backs Capital Flexibility and New Long-Term Incentive Plan

Claim 55% Off TipRanks

Vimian Group AB ( (SE:VIMIAN) ) has provided an update.

Vimian Group AB’s Annual General Meeting approved the 2025 financial statements, discharged the board and CEOs from liability, and decided that no dividend will be paid, with profits carried forward. Shareholders re-elected the existing five-member board, confirmed Magnus Welander as chair, reappointed Grant Thornton Sweden AB as auditor, and set board and committee remuneration levels.

The meeting authorised the board to issue new shares of up to 20 percent of the outstanding share capital and to repurchase up to 10 percent of the company’s own shares to optimise capital structure, enable share-based transactions, and support incentive schemes. Shareholders also approved a new Articles of Association introducing reclassifiable and redeemable share classes for incentive use, and adopted a long-term performance-based share programme, LTIP 2026/2029, underlining Vimian’s focus on employee alignment and long-term value creation.

The most recent analyst rating on (SE:VIMIAN) stock is a Hold with a SEK37.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.

More about Vimian Group AB

Vimian Group AB is a Swedish publicly listed company operating in the animal health sector, focusing on specialized veterinary products and services. The group targets a global market for advanced care solutions for companion and production animals, positioning itself as a consolidator and growth platform in veterinary pharmaceuticals and related technologies.

Average Trading Volume: 299,245

Technical Sentiment Signal: Hold

Current Market Cap: SEK15.02B

See more data about VIMIAN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1